ConfidaRecalls & reported problems across all models

We found 4 models of Confida by Medtronic, Inc. in the FDA's device registry (GUDID). Together they are named in 53 adverse event reports in the FDA's MAUDE database, received between Jul 13, 2017 and Sep 15, 2026 — classified as 31 deaths, 20 injuries, 2 malfunctions.

The most frequently reported specific device problem is “Patient Device Interaction Problem” (18 reports).

1 FDA recall record name at least one of these models by its device identifier.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works

Confida recalls

FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.

1. May 12, 2020Terminated

   Increased risk of events associated with vascular complications (bleeding, hematoma, and dissection)

   Z-2039-2020 · Root cause: Process control · Recall details · FDA record ↗

Most reported Confida problems

Confida models

4 models, most reported first. Each model has its own page with its reports, recalls and device details.

• Confida™ CES122230

  INTRODUCER, CATHETER
  1 recall1 report
• Confida™ GWBC30

  Wire, guide, catheter
  21 deaths33 reports
• Confida™ GWBC30

  Wire, guide, catheter
  6 deaths10 reports
• Confida™ GWBC30

  WIRE, GUIDE, CATHETER
  4 deaths9 reports

Recent Confida adverse event reports

The 15 most recent reports across all models, in the reporter's own words as published by the FDA.

• InjurySep 15, 2026Device Dislodged or Dislocated; Positioning Problem; Patient Device Interaction Problem

  Patient problems: Aortic dissection

  MAUDE report 50780041 ↗
• InjuryJul 27, 2026Device Difficult to Setup or Prepare; Patient Device Interaction Problem

  It was reported that prior to the implant of a transcatheter aortic valve (TAV), during the loading phase, a bent strut was visually observed after "marrying" the tip guide tube and the outflow cone, constituting a misload. Subsequently, the valve was removed and the same delivery catheter system (DCS) and compression loading system (CLS) were used to load a new valve. Following the successful loading of the second valve, a Confida guidewire was inserted into the patient, and complete heart block (CHB) was observed. Temporary pacing was then initiated for the rest of the procedure. A pre-implant balloon aortic valvuloplasty (BAV) was performed with a non-Medtronic (Beckton Dickson True) 22 millimeter (mm) balloon, and the DCS was inserted into the patient via the right carotid artery. Following successful deployment of the valve, the temporary pacing was turn off, however the CHB remained. Subsequently, a permanent pacemaker was implanted. A procedural delay of 3 hours occurred as a result. Additional information was received to report the valve load was performed by an experienced valve loader. The misload was identified via visual inspection and was "seen early enough that we did

  Patient problems: Heart Block

  MAUDE report 50012469 ↗
• DeathApr 11, 2026Insufficient Device Problem Information; Patient Device Interaction Problem

  IT WAS REPORTED THAT DURING A TRANSCATHETER AORTIC VALVE IMPLANT PROCEDURE, A PRE-IMPLANT BALLOON AORTIC VALVULOPLASTY (BAV) WAS COMPLETED DUE TO CALCIFICATION. THE DELIVERY CATHETER SYSTEM (DCS) WAS THEN INSERTED INTO THE PATIENT AND ADVANCED TO THE NATIVE AORTIC ANNULUS. THE VALVE WAS THEN PARTIALLY DEPLOYED IN THAT IT WAS POSITIONED APPROXIMATELY 4 MILLIMETERS (MM) FROM THE NON-CORONARY CUSP (NCC) AND 4 MM FROM THE LEFT CORONARY CUSP (LCC). DESPITE FOLLOWING TRAINING GUIDANCE FOR SLOW DEPLOYMENT OF THE VALVE AND CENTERING OF THE DCS NOSECONE BY SLIGHTLY RETRACTING THE GUIDEWIRE, THE NOSECONE SUDDENLY MOVED DURING FINAL DEPLOYMENT, CAUSING DCS INTERACTION WITH THE VALVE. THIS INTERACTION CAUSED THE VALVE TO EMBOLIZE INTO THE PATIENT'S ASCENDING AORTA. SUBSEQUENTLY, THE ATTENDING PHYSICIAN OPTED TO ATTEMPT IMPLANTATION OF A SECOND VALVE, SO A NEW VALVE WAS PREPARED AND LOADED INTO THE DCS. AS THE DCS WAS ADVANCED TOWARDS THE AORTIC ANNULUS, THE PREVIOUSLY DISLODGED VALVE BECAME UNSTABLE. THEREFORE, A SNARE WAS UTILIZED TO GRASP THE DISLODGED VALVE TO MAINTAIN ITS POSITION IN RELATION TO THE GREAT VESSELS AS THE SECOND VALVE WAS SUCCESSFULLY IMPLANTED. AFTER IMPLANTATION OF THE SEC

  Patient problems: Cardiac Arrest; Pericardial Effusion; Rupture

  MAUDE report 24848153 ↗
• DeathJan 14, 2026Difficult to Advance; Patient Device Interaction Problem

  IT WAS REPORTED THAT DURING THE IMPLANT PROCEDURE OF A TRANSCATHETER VALVE, DURING DELIVERY CATHETER SYSTEM (DCS) ADVANCEMENT, THE DCS WAS DIFFICULT TO ADVANCE THROUGH THE PATIENT'S HEAVILY CALCIFIED AORTIC ARCH. AFTER SEVERAL ATTEMPTS, THE DCS WAS ABLE TO PASS AND THE VALVE WAS IMPLANTED. FOLLOWING THE IMPLANT PROCEDURE, THE PATIENT EXPERIENCED A STROKE AND RECEIVED TREATMENT; HOWEVER, THE PATIENT DIED. ADDITIONAL INFORMATION WAS RECEIVED THAT FOLLOWING THE VALVE IMPLANT, THE STROKE WAS HEMORRHAGIC AND CONFIRMED BY PATIENT SYMPTOMS (LOSS OF CONSCIOUSNESS AND HEMIPARESIS) AND COMPUTED TOMOGRAPHY (CT). PER THE PHYSICIAN, THE VALVE DID NOT CONTRIBUTE TO THE STROKE BUT DUE TO VARIOUS ATTEMPTS TO CROSS THE CALCIFIED AORTIC ARCH THE DELIVERY CATHETER SYSTEM (DCS) MAY HAVE CONTRIBUTED TO CALCIUM DISPLACEMENT. THE CAUSE OF THE STROKE WAS CALCIUM DISPLACEMENT FROM THE AORTIC ARCH. THE PATIENT WAS HOSPITALIZED AND MEDICAL MANAGEMENT WAS USED TO TREAT THE STROKE. THE CAUSE OF DEATH WAS DUE TO THE STROKE.

  Patient problems: Stroke/CVA

  MAUDE report 24067535 ↗
• DeathJan 8, 2026Patient Device Interaction Problem

  IT WAS REPORTED THAT FOLLOWING THE SUCCESSFUL IMPLANT OF A TRANSCATHETER VALVE, UPON WITHDRAWING THE WIRE, THE VALVE WAS PULLED AND DISLODGED. A SNARE WAS USED TO STABILIZE THE DISLODGED VALVE IN THE ASCENDING AORTA, AND A SECOND VALVE WAS IMPLANTED. IMMEDIATELY AFTER THE IMPLANT OF THE SECOND VALVE, HYPOTENSION AND BRADYCARDIA WERE OBSERVED. AN ECHOCARDIOGRAM WAS PERFORMED THAT REVEALED A LARGE PERICARDIAL EFFUSION. SUBSEQUENTLY, RESUSCITATION WAS PERFORMED, INCLUDING CARDIAC MASSAGE, TEMPORARY PACING, AND PERICARDIAL DRAINAGE. EMERGENCY SURGERY WAS PERFORMED VIA LEFT ANTERIOR THORACOTOMY IN THE APICAL AREA. AT THE END OF THE PROCEDURE, BLEEDING HAD CEASED AND THE PATIENT WAS HEMODYNAMICALLY STABLE. APPROXIMATELY 5 HOURS FOLLOWING THE IMPLANT PROCEDURE, THE PATIENT DIED. THE PHYSICIAN ASSESSED THAT DURING THE IMPLANT OF THE SECOND VALVE, THE MEDTRONIC (CONFIDA) GUIDEWIRE CAUSED A LEFT VENTRICLE PERFORATION THAT RESULTED IN TAMPONADE AND SUBSEQUENT DEATH. PER THE PHYSICIAN, THE EVENT WAS A PROCEDURE RELATED COMPLICATION, WITH NO CLAIMS AGAINST THE VALVE OR DELIVERY CATHETER SYSTEM (DCS). ADDITIONAL INFORMATION WAS RECEIVED THAT A PRE-IMPLANT BALLOON DILATION WAS NOT PERFORMED AND A

  Patient problems: Bradycardia; Cardiac Perforation; Cardiac Tamponade; Low Blood Pressure/ Hypotension; Pericardial Effusion

  MAUDE report 24006430 ↗
• InjuryNov 12, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

  IT WAS REPORTED THAT FOLLOWING THE IMPLANT OF A TRANSCATHETER VALVE, UPON PERFORMING HEMOSTASIS, FLUOROSCOPY REVEALED A DESCENDING AORTIC DISSECTION. SUBSEQUENTLY, THE PATIENT WAS TRANSFERRED TO UNDERGO A COMPUTED TOMOGRAPHY (CT) SCAN TO DETERMINE TREATMENT. ADDITIONAL INFORMATION WAS RECEIVED THAT PER THE PHYSICIAN, THE DELIVERY CATHETER SYSTEM (DCS) AND MEDTRONIC GUIDEWIRE CAUSED THE DESCENDING AORTIC DISSECTION. A COMPUTED TOMOGRAPHY (CT) SCAN WAS PERFORMED, AND MEDICATION WAS ADMINISTERED TO TREAT THE DISSECTION. THE PATIENT WAS SUBSEQUENTLY DISCHARGED.

  Patient problems: Aortic dissection

  MAUDE report 23533902 ↗
• DeathOct 30, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

  IT WAS REPORTED THAT DURING THE ATTEMPTED IMPLANT OF A TRANSCATHETER VALVE, THE VALVE WAS RECAPTURED TO REPOSITION IT; HOWEVER, THE PATIENT BEGAN TO DECOMPENSATE. SUBSEQUENTLY, CARDIAC MASSAGE AND CARDIOPULMONARY RESUSCITATION (CPR) WERE INITIATED. AN ECHOCARDIOGRAM WAS PERFORMED THAT REVEALED A PERICARDIAL EFFUSION, AND A PERFORATED/TORN VENTRICLE BY THE MEDTRONIC (CONFIDA) GUIDEWIRE. SUBSEQUENTLY, SURGICAL REPAIR WAS PERFORMED; HOWEVER, THE PATIENT DIED DURING THE PROCEDURE. PER THE PHYSICIAN, THE CAUSE OF DEATH WAS DUE TO COMPLICATIONS WITH THE PERICARDIAL EFFUSION. IT WAS NOTED THAT THE TRANSCATHETER VALVE DID NOT CONTRIBUTE TO THE DEATH, AND WAS NEVER IMPLANTED.

  Patient problems: Cardiac Perforation; Pericardial Effusion

  MAUDE report 23428215 ↗
• MalfunctionOct 17, 2025Peeled/Delaminated; Peeled/Delaminated

  IT WAS REPORTED THAT THE TIP OF THE GUIDEWIRE GWBC30 CONFIDA 26L WAS FOUND TO BE FRAYED WHEN REMOVED FROM ITS ORIGINAL PACKAGING, AND AN ALLEGED PRODUCT ISSUE WAS IDENTIFIED. THE WIRE WAS NOT USED, AND THERE WAS NO EFFECT ON THE PATIENT. THE HEALTHCARE PROFESSIONAL SELECTED A NEW WIRE AND CONTINUED THE PROCEDURE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

  Patient problems: No Clinical Signs, Symptoms or Conditions

  MAUDE report 23323695 ↗
• DeathJul 28, 2025Difficult or Delayed Positioning; Patient Device Interaction Problem; Difficult or Delayed Positioning; Patient Device Interaction Problem

  ADDITIONAL INFORMATION WAS RECEIVED THAT THE PHYSICIAN THOUGHT THAT SEQUESTRATION (WHEN THE CUSPS OF THE NATIVE AORTIC VALVE OR A PREVIOUS PROSTHESIS ARE DISPLACED BY THE NEW VALVE) OF THE SINUSES OF VALSALVA MAY HAVE OCCURRED WHICH MAY HAVE LEAD TO ACUTE CORONARY OBSTRUCTION.

  Patient problems: Coronary obstruction/occlusion; Hemodynamic instability; Low Blood Pressure/ Hypotension

  MAUDE report 22631800 ↗
• InjuryJul 18, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated

  IT WAS REPORTED THAT DURING THE IMPLANT OF THIS TRANSCATHETER BIOPROSTHETIC VALVE, FOLLOWING FULL DEPLOYMENT, A POST-IMPLANT BALLOON DILATION WAS PERFORMED USING A 22 MM BALLOON. UPON REMOVAL, THE BALLOON INTERACTED WITH THE MEDTRONIC GUIDEWIRE. THIS INTERACTION CAUSED THE VALVE TO DISLODGE FROM POSITION. SUBSEQUENTLY, A SECOND VALVE WAS IMPLANTED IN THE PATIENT. ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT THE POST-DILATION WAS PERFORMED DUE TO A PARAVALVULAR LEAK. THE PATIENT WAS RAPID PACED DURING THE POST-IMPLANT BALLOON DILATION. THE VALVE IMPLANT DEPTH WAS ORIGINALLY 4 MM, BUT IT DISLODGED IN THE AORTIC DIRECTION. THE SECOND VALVE WAS IMPLANTED AT A DEPTH OF 3 MM ON THE NON-CORONARY CUSP AND LEFT CORONARY CUSP.

  Patient problems: Foreign Body In Patient

  MAUDE report 22542863 ↗
• DeathApr 25, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

  ADDITIONAL INFORMATION WAS RECEIVED THAT THE VENTRICULAR PERFORATION WAS TREATED WITH PERICARDIOCENTESIS. PER THE PHYSICIAN, THE VALVE AND THE DCS COULD BE EXCLUDED AS CONTRIBUTING FACTORS TO THE DEATH. ADDITIONALLY, THE PATIENT HAD A SMALL LEFT VENTRICLE THAT CONTRIBUTED TO THE DEATH.

  Patient problems: Perforation

  MAUDE report 21912628 ↗
• DeathMar 27, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

  ADDITIONAL INFORMATION WAS RECEIVED WHICH INDICATED THAT PER THE PHYSICIAN, NEITHER THE GUIDEWIRE, VALVE, NOR THE DELIVERY CATHETER SYSTEM CAUSED OR CONTRIBUTED TO THE ADVERSE EVENTS.

  Patient problems: Cardiac Arrest; Ventricular Fibrillation

  MAUDE report 21709183 ↗
• MalfunctionFeb 7, 2024Peeled/Delaminated; Material Twisted/Bent; Peeled/Delaminated; Material Twisted/Bent

  MEDTRONIC RECEIVED INFORMATION THAT DURING THE USE OF THIS CONFIDA GUIDEWIRE, THE WIRE WAS REPORTED TO HAVE BROKE. FURTHER DETAILS ON THE BROKEN WIRE WERE NOT PROVIDED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

  Patient problems: Insufficient Information

  MAUDE report 18661031 ↗
• DeathOct 23, 2023Insufficient Device Problem Information; Patient Device Interaction Problem; Insufficient Device Problem Information; Patient Device Interaction Problem

  MEDTRONIC RECEIVED INFORMATION THAT AN UNKNOWN TIME DURING THE IMPLANT OF A TRANSCATHETER BIOPROSTHETIC VALVE, A LEFT VENTRICLE PERFORATION WAS REPORTED AND THE PATIENT DIED. THE CAUSE OF DEATH WAS NOT REPORTED.

  Patient problems: Perforation

  MAUDE report 17990358 ↗
• DeathOct 20, 2023Patient Device Interaction Problem; Patient Device Interaction Problem

  ADDITIONAL INFORMATION WAS RECEIVED THAT DURING THE IMPLANT OF THE TRANSCATHETER BIOPROSTHETIC VALVE, THE TIP OF THE GUIDEWIRE WAS NOT MANIPULATED PRIOR TO USE. THE GUIDEWIRE WAS PLACED IN THE APEX OF THE LEFT VENTRICLE USING A PIGTAIL CATHETER. THE GUIDEWIRE POSITION WAS MONITORED THROUGHOUT THE PROCEDURE AND WAS NOT REPOSITIONED. THE GUIDEWIRE POSITION WAS VISUALLY MONITORED USING TWO PROJECTIONS. PER THE PHYSICIAN, THE CAUSE OF THE LEFT VENTRICLE PERFORATION WAS UNKNOWN AND UNKNOWN IF THE GUIDEWIRE CONTRIBUTED TO THE EVENT.

  Patient problems: Cardiac Tamponade; Perforation

  MAUDE report 17977549 ↗

Other Medtronic, Inc. products

• CapSureFix Novus MRI SureScan29 models · 87,337 reports
• Medtronic Sprint Quattro Lead67 models · 45,880 reports · 1 recall
• Intellis AdaptiveStim3 models · 35,469 reports
• SYNCHROMED II11 models · 32,260 reports · 4 recalls
• CAPSUREFIX NOVUS17 models · 27,547 reports
• INTERSTIM30 models · 24,415 reports · 1 recall
• Sprint Quattro Secure S MRI SureScan7 models · 23,549 reports
• Medtronic LINQ Heart Monitor11 models · 19,366 reports · 3 recalls